Strong Q1; full-year outlook maintained
12/05/22 -"Alcon has started 2022 on a good note, with continued strong growth momentum being witnessed across the segments. While spiralling inflation and FX headwinds, due to rising geopolitical crisis and ..."
Pages
50
Language
English
Published on
12/05/22
You may also be interested by these reports :
12/09/25
DiaSorin appears to be making significant progress in the testing space. The launch of speciality tests, introduction of the Plex platform, and ...
05/09/25
Bastide reported FY24/25 revenue in line with guidance and our forecast. The more technical business activities remain the primary driver of organic ...
05/09/25
Since we last pushed Philips’ (Buy; Netherlands) investment case in January 2024, its share price performance has been glaringly ahead of the MedTech ...
04/09/25
bioMerieux’s H1 profitability surpassed expectations. Topline growth was driven by robust performance across both segments. However, weakness in ...